Baseline Gut Microbiome and Metabolite Profiles Associate with Treatment Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
<b>Background/Objectives:</b> Response to neoadjuvant chemotherapy (NAC) varies substantially among breast cancer patients and is only partially explained by tumor-intrinsic factors. The gut microbiome has emerged as a potential modulator of chemotherapy efficacy, yet its role in breast cancer remai...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2026-02-01
|
| Serier: | Diagnostics |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2075-4418/16/3/433 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
